View in EDS

American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy

Saved in:
Bibliographic Details
Title: American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy
Authors: Nag, Subir1 nag.1@osu.edu, Ellis, Rodney J.1, Merrick, Gregory S.1, Bahnson, Robert1, Wallner, Kent1, Stock, Richard1
Source: International Journal of Radiation Oncology, Biology, Physics. Oct2002, Vol. 54 Issue 2, p462. 9p.
Subjects: Prostate diseases, Radiotherapy, Quality of life
Abstract: Purpose: To standardize the reporting of brachytherapy-related prostate morbidity to guide ongoing clinical practice and future investigations.Methods: Members of the American Brachytherapy Society (ABS) with expertise in prostate brachytherapy performed a literature review and, guided by their clinical experience, formulated specific recommendations for reporting on morbidity related to prostate brachytherapy.Results: The ABS recommends using validated, patient-administered health-related quality-of-life instruments for the determination of baseline and follow-up data regarding bowel, urinary, and sexual function. Both actuarial and crude incidences should be reported, along with the temporal resolution of specific complications, and correlated with the doses to the normal tissues. The International Prostate Symptom Score is recommended to assess urinary morbidity, and any dysuria, gross hematuria, urinary retention, incontinence, or medication use should be quantified. Likewise, the “Sexual Health Inventory for Men,” which includes the specific erectile questions of the International Index of Erectile Function, is the preferred instrument for reporting sexual function, and the loss of sexual desire, incidence of hematospermia, painful orgasm (orgasmalgia), altered orgasm intensity, decreased ejaculatory volume, use of erectile aids, and use of hormones for androgen deprivation should be quantified. The ABS recommends adoption of the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer acute and late radiation morbidity scoring scheme for reporting rectal morbidity and noting the incidence of rectal steroid, laser, or antidiarrheal use.Conclusion: It is important to focus on health-related quality-of-life issues in the treatment of prostate cancer, because the control rates are very similar between appropriate treatment modalities. The ABS recommends using the International Prostate Symptom Score, International Index of Erectile Function, and Radiation Therapy Oncology Group toxicity grading criteria for the determination of urinary, sexual, and bowel function, respectively. Additional parameters for reporting urinary, rectal, and sexual morbidities are presented. These morbidities should be correlated with the doses to the normal tissues. Some of these specific recommendations may be modified if and when new data become available. [Copyright &y& Elsevier]
Copyright of International Journal of Radiation Oncology, Biology, Physics is the property of Pergamon Press - An Imprint of Elsevier Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 7878601
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Nag%2C+Subir%22">Nag, Subir</searchLink><relatesTo>1</relatesTo><i> nag.1@osu.edu</i><br /><searchLink fieldCode="AR" term="%22Ellis%2C+Rodney+J%2E%22">Ellis, Rodney J.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Merrick%2C+Gregory+S%2E%22">Merrick, Gregory S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Bahnson%2C+Robert%22">Bahnson, Robert</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Wallner%2C+Kent%22">Wallner, Kent</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Stock%2C+Richard%22">Stock, Richard</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Radiation+Oncology%2C+Biology%2C+Physics%22">International Journal of Radiation Oncology, Biology, Physics</searchLink>. Oct2002, Vol. 54 Issue 2, p462. 9p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Prostate+diseases%22">Prostate diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Radiotherapy%22">Radiotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+life%22">Quality of life</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: <UNL TYPE="BAR" STYLE="S">Purpose</UNL>: To standardize the reporting of brachytherapy-related prostate morbidity to guide ongoing clinical practice and future investigations.<UNL TYPE="BAR" STYLE="S">Methods</UNL>: Members of the American Brachytherapy Society (ABS) with expertise in prostate brachytherapy performed a literature review and, guided by their clinical experience, formulated specific recommendations for reporting on morbidity related to prostate brachytherapy.<UNL TYPE="BAR" STYLE="S">Results</UNL>: The ABS recommends using validated, patient-administered health-related quality-of-life instruments for the determination of baseline and follow-up data regarding bowel, urinary, and sexual function. Both actuarial and crude incidences should be reported, along with the temporal resolution of specific complications, and correlated with the doses to the normal tissues. The International Prostate Symptom Score is recommended to assess urinary morbidity, and any dysuria, gross hematuria, urinary retention, incontinence, or medication use should be quantified. Likewise, the “Sexual Health Inventory for Men,” which includes the specific erectile questions of the International Index of Erectile Function, is the preferred instrument for reporting sexual function, and the loss of sexual desire, incidence of hematospermia, painful orgasm (orgasmalgia), altered orgasm intensity, decreased ejaculatory volume, use of erectile aids, and use of hormones for androgen deprivation should be quantified. The ABS recommends adoption of the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer acute and late radiation morbidity scoring scheme for reporting rectal morbidity and noting the incidence of rectal steroid, laser, or antidiarrheal use.<UNL TYPE="BAR" STYLE="S">Conclusion</UNL>: It is important to focus on health-related quality-of-life issues in the treatment of prostate cancer, because the control rates are very similar between appropriate treatment modalities. The ABS recommends using the International Prostate Symptom Score, International Index of Erectile Function, and Radiation Therapy Oncology Group toxicity grading criteria for the determination of urinary, sexual, and bowel function, respectively. Additional parameters for reporting urinary, rectal, and sexual morbidities are presented. These morbidities should be correlated with the doses to the normal tissues. Some of these specific recommendations may be modified if and when new data become available. [Copyright &y& Elsevier]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of International Journal of Radiation Oncology, Biology, Physics is the property of Pergamon Press - An Imprint of Elsevier Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=7878601
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0360-3016(02)02937-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 462
    Subjects:
      – SubjectFull: Prostate diseases
        Type: general
      – SubjectFull: Radiotherapy
        Type: general
      – SubjectFull: Quality of life
        Type: general
    Titles:
      – TitleFull: American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nag, Subir
      – PersonEntity:
          Name:
            NameFull: Ellis, Rodney J.
      – PersonEntity:
          Name:
            NameFull: Merrick, Gregory S.
      – PersonEntity:
          Name:
            NameFull: Bahnson, Robert
      – PersonEntity:
          Name:
            NameFull: Wallner, Kent
      – PersonEntity:
          Name:
            NameFull: Stock, Richard
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2002
              Type: published
              Y: 2002
          Identifiers:
            – Type: issn-print
              Value: 03603016
          Numbering:
            – Type: volume
              Value: 54
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: International Journal of Radiation Oncology, Biology, Physics
              Type: main
ResultId 1